Press release
The acidity of tumours impairs the effectiveness of anti-cancer therapies, according to a University of Dundee study that could lead to a new generation of immunotherapy treatments
Press release
The acidity of tumours impairs the effectiveness of anti-cancer therapies, according to a University of Dundee study that could lead to a new generation of immunotherapy treatments
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee has received an award of funding to develop a new therapeutic approach for inflammatory disorders, including inflammatory bowel disease (IBD)
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
Professor Grahame Hardie, from the School of Life Sciences, has been awarded the prestigious Sir Philip Randle Lecture in recognition of his record of excellence in biochemistry
News
Martin Balcerowicz joined the School in January to establish his own laboratory in the Division of Plant Sciences.
News
Kirby Swatek opened an independent research laboratory in the MRC PPU at the beginning of 2022.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.